What is BioLife Solutions?
BioLife Solutions is a science-led company dedicated to enhancing the development and delivery of cell and gene therapies. The company designs, manufactures, and supplies critical biopreservation media, closed-system cell processing tools, cryogenic storage and transport solutions, and regulatory support. These offerings are designed to protect living cells throughout complex bioprocessing workflows, safeguarding therapeutic integrity from research through clinical application. BioLife Solutions' proprietary technologies are instrumental in streamlining workflows and supporting scientists and manufacturers in overcoming preservation challenges inherent in regenerative medicine.
How much funding has BioLife Solutions raised?
BioLife Solutions has raised a total of $15.4M across 1 funding round:
Stock Offering
$15.4M
Stock Issuance/Offering (2014): $15.4M, investors not publicly disclosed
What's next for BioLife Solutions?
The recent major strategic investment in BioLife Solutions signals a strong confidence in the company's trajectory and its capacity to scale operations. This capital is expected to fuel further innovation in biopreservation technologies and expand market reach within the rapidly growing cell and gene therapy industry. The company is well-positioned to capitalize on the increasing demand for robust solutions that ensure cellular viability and therapeutic efficacy throughout the bioprocessing lifecycle, potentially leading to further enterprise-level growth and strategic partnerships.
See full BioLife Solutions company page
